Upgrade to SI Premium - Free Trial

Xenon Pharmaceuticals (XENE)

51.80 +0.59 (1.15%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 4 Xenon Pharmaceuticals For: Jun 05 Filed by: PATOU GARY June 8, 2026 9:20 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 05 Filed by: Cannon Gillian June 8, 2026 9:19 PM - SEC Filing Form 144 Xenon Pharmaceuticals Filed by: Cannon Gillian June 5, 2026 4:33 PM - SEC Filing Form 144 Xenon Pharmaceuticals Filed by: PATOU GARY June 5, 2026 4:32 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: PATOU GARY June 3, 2026 9:05 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: Machado Patrick June 3, 2026 9:05 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: Gover Justin D. June 3, 2026 9:05 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: GAROFALO ELIZABETH A. June 3, 2026 9:04 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: GANNON STEVEN June 3, 2026 9:04 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: Cannon Gillian June 3, 2026 9:04 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Jun 01 Filed by: Svoronos Dawn June 3, 2026 9:04 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:28 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:27 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:26 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:25 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:23 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:22 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:20 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:18 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:12 PM - SEC Filing Form S-8 POS Xenon Pharmaceuticals June 3, 2026 4:10 PM - SEC Filing Form S-8 Xenon Pharmaceuticals June 3, 2026 4:06 PM - SEC Filing Form 8-K Xenon Pharmaceuticals For: Jun 02 June 3, 2026 4:02 PM - SEC Filing Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 29, 2026 4:01 PM - StreetInsider Xenon Pharmaceuticals (XENE) PT Raised to $82 at JPMorgan May 27, 2026 7:58 AM - StreetInsider Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 11:24 AM - SEC Filing Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: Avoro Capital Advisors LLC May 15, 2026 8:17 AM - SEC Filing Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC May 15, 2026 7:07 AM - SEC Filing Form 4 Xenon Pharmaceuticals For: May 12 Filed by: GANNON STEVEN May 13, 2026 9:41 PM - SEC Filing Xenon Pharmaceuticals (XENE) PT Raised to $80 at JPMorgan May 12, 2026 8:08 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Raised to $82 at RBC Capital May 8, 2026 7:41 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $78 at Needham May 8, 2026 7:29 AM - StreetInsider Xenon Pharmaceuticals (XENE) Tops Q1 EPS by 1c May 7, 2026 5:47 PM - StreetInsider Form 10-Q Xenon Pharmaceuticals For: Mar 31 May 7, 2026 4:37 PM - SEC Filing Form 8-K Xenon Pharmaceuticals For: May 07 May 7, 2026 4:03 PM - SEC Filing Xenon Reports Q1 2026 Financial Results and Provides Business Update May 7, 2026 4:01 PM - StreetInsider Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 1, 2026 4:01 PM - Globe NewsWire Xenon to Report Q1 2026 Financial Results on May 7, 2026 April 30, 2026 4:01 PM - StreetInsider Form ARS Xenon Pharmaceuticals For: Dec 31 April 22, 2026 4:06 PM - SEC Filing Form DEFA14A Xenon Pharmaceuticals April 22, 2026 4:04 PM - SEC Filing Form DEF 14A Xenon Pharmaceuticals For: Apr 22 April 22, 2026 4:03 PM - SEC Filing Stifel on Xenon Pharmaceuticals (XENE): 'We continue to believe >$2B US peak sales in FOS is very realistic' April 20, 2026 6:31 AM - StreetInsider Xenon reports phase 3 epilepsy drug trial results at neurology meeting April 19, 2026 6:00 PM - StreetInsider Xenon presents positive Phase 3 epilepsy trial results at neurology meeting April 19, 2026 6:00 PM - StreetInsider Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting April 19, 2026 6:00 PM - Globe NewsWire Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting April 19, 2026 6:00 PM - StreetInsider Xenon to Present at Upcoming Investor Conferences April 15, 2026 8:30 AM - Globe NewsWire Form S-8 Xenon Pharmaceuticals April 13, 2026 4:05 PM - SEC Filing Form 8-K Xenon Pharmaceuticals For: Apr 07 April 13, 2026 4:01 PM - SEC Filing Bernstein on US Pharma and Biotech: Who might buy whom? April 13, 2026 5:52 AM - StreetInsider Xenon Pharmaceuticals to present epilepsy drug data at neurology meeting April 7, 2026 12:47 PM - StreetInsider Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting April 7, 2026 12:47 PM - Globe NewsWire Xenon Pharmaceuticals to present azetukalner data at neurology meeting April 7, 2026 8:42 AM - StreetInsider Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting April 7, 2026 8:41 AM - StreetInsider William Blair Shuffles Analyst Conviction List for April 2026 April 1, 2026 7:15 AM - StreetInsider RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns' March 18, 2026 9:21 AM - StreetInsider Xenon Pharmaceuticals (XENE) PT Lowered to $63 at Wedbush March 16, 2026 6:44 AM - StreetInsider Form 4 Xenon Pharmaceuticals For: Mar 12 Filed by: KENNEY CHRISTOPHER JOHN March 13, 2026 8:17 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Mar 12 Filed by: DiFabio Andrea March 13, 2026 8:17 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Mar 12 Filed by: MORTIMER IAN March 13, 2026 8:16 PM - SEC Filing Form 144 Xenon Pharmaceuticals Filed by: KENNEY CHRISTOPHER JOHN March 13, 2026 7:51 PM - SEC Filing Form 144 Xenon Pharmaceuticals Filed by: DiFabio Andrea March 13, 2026 7:50 PM - SEC Filing Form 144 Xenon Pharmaceuticals Filed by: MORTIMER IAN March 13, 2026 7:50 PM - SEC Filing Form 8-K Xenon Pharmaceuticals For: Mar 13 March 13, 2026 4:11 PM - SEC Filing Xenon Pharmaceuticals (XENE) PT Raised to $77 at BofA Securities March 12, 2026 4:40 PM - StreetInsider Form 8-K Xenon Pharmaceuticals For: Mar 10 March 12, 2026 4:20 PM - SEC Filing Xenon Pharmaceuticals closes $747.5 million public offering March 12, 2026 4:01 PM - StreetInsider Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares March 12, 2026 4:01 PM - StreetInsider Form 424B5 Xenon Pharmaceuticals March 12, 2026 6:01 AM - SEC Filing Form 4 Xenon Pharmaceuticals For: Mar 09 Filed by: KENNEY CHRISTOPHER JOHN March 11, 2026 7:21 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Mar 09 Filed by: DiFabio Andrea March 11, 2026 7:21 PM - SEC Filing Form 4 Xenon Pharmaceuticals For: Mar 09 Filed by: MORTIMER IAN March 11, 2026 7:20 PM - SEC Filing Form FWP Xenon Pharmaceuticals Filed by: Xenon Pharmaceuticals Inc. March 11, 2026 6:03 AM - SEC Filing Full Article List